Drug news
Serada (Depomed) filed at FDA for treatment of Hot Flashes
Depomed Inc., has submitted a New Drug Application (NDA) for Serada (gabapentin GR) to the FDA. Serada is a proprietary extended release formulation of gabapentin in development for the treatment of Menopausal Hot Flashes.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.